Dr. Pankaj Malhotra, MD

Dr. Malhotra practices at Progressive Urgent Care Modesto in Modesto, California.

Dr. Malhotra's NPI, 1851561203, was assigned on February 29, 2008. Dr. Malhotra graduated from Netaji S Chandra Bose Medical College in 2003. Dr. Malhotra holds California license A113872.

Dr. Malhotra's primary practice is Progressive Urgent Care Modesto, at 801 17th St, Modesto, CA 95354. The practice phone is (209) 251-0200.

Dr. Malhotra's primary practice is Progressive Urgent Care Modesto in Modesto, California. Dr. Malhotra is also affiliated with Doctors Medical Center Modesto. The medical group on file is Vituity. Dmand AI also links Dr. Malhotra to 2 more hospitals and 9 medical groups, each named with a free account. Dr. Malhotra's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malhotra practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Malhotra's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Malhotra is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Malhotra's licenses on file in 2 states: California and Connecticut.

Dmand AI lists acid reflux, acute diabetes, acute gastroduodenitis, acute respiratory failure, acute sinusitis, acute skin infection, alcohol use disorders and anemia among the conditions Dr. Malhotra treats.

CMS data shows 1,935 Medicare services from Dr. Malhotra across 18 procedure codes in 2024, for 721 Medicare patients. Medicare paid $153,356 for them.

CMS counts 721 Medicare patients who saw Dr. Malhotra in 2024. The largest group is 65 to 74, with 334 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 78% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malhotra's median patient age at 33, with 59% women.

In 2024, Dr. Malhotra wrote 61 Medicare Part D claims for 23 patients. 93% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $161 in total drug cost. In 2021, CMS named 69 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 30 out of 100 for Dr. Malhotra for performance year 2024, reported individually. Dr. Malhotra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malhotra as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 555 papers to Dr. Malhotra, published from 2011 to 2025. 2024 was the busiest year, with 52. The most frequent topics are India, Multiple Myeloma and Antineoplastic Combined Chemotherapy Protocols. Dr. Malhotra has published most often in Indian J Hematol Blood Transfus. Dr. Malhotra's most frequent co-authors are Vikas Suri, MD, Sandeep Grover, MD and Ashish Bhalla, MD.

Dmand AI links Dr. Malhotra to 1 clinical trial. Conditions studied include Multiple Myeloma and Blood Protein Disorders.

CMS Open Payments shows 38 general payments to Dr. Malhotra from 11 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $215.

Dr. Malhotra graduated from Netaji S Chandra Bose Medical College in 2003. Dr. Malhotra is a member of SHM.

Dr. Malhotra is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.